MediXall Group, Inc. (MDXL)
OTCMKTS
· Delayed Price · Currency is USD
0.0036
-0.0025 (-40.98%)
At close: Nov 21, 2024
MediXall Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2015 |
| Revenue | 0.24 | 0.06 | 0.01 | - | 0 | 0 | Upgrade
|
| Revenue Growth (YoY) | - | 295.25% | - | - | 44.51% | -91.64% | Upgrade
|
| Cost of Revenue | 1.45 | 3.2 | 3.07 | 2.53 | 1.37 | 1.71 | Upgrade
|
| Gross Profit | -1.21 | -3.14 | -3.05 | -2.53 | -1.37 | -1.71 | Upgrade
|
| Selling, General & Admin | 3.18 | 3.36 | 3.33 | 2.78 | 2.05 | 1.19 | Upgrade
|
| Other Operating Expenses | -0.18 | -0.18 | -0.02 | 0.62 | - | - | Upgrade
|
| Operating Expenses | 3 | 3.18 | 3.31 | 3.4 | 2.05 | 1.19 | Upgrade
|
| Operating Income | -4.21 | -6.32 | -6.37 | -5.93 | -3.42 | -2.9 | Upgrade
|
| Interest Expense | -0.44 | -0.27 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -4.65 | -6.59 | -6.37 | -5.93 | -3.42 | -2.9 | Upgrade
|
| Asset Writedown | -0.24 | -0.24 | - | - | - | -0.09 | Upgrade
|
| Other Unusual Items | - | - | 0.17 | - | - | - | Upgrade
|
| Pretax Income | -4.89 | -6.83 | -6.2 | -5.93 | -3.42 | -2.98 | Upgrade
|
| Net Income | -4.89 | -6.83 | -6.2 | -5.93 | -3.42 | -2.98 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.31 | 0.31 | 0.25 | 0.04 | - | - | Upgrade
|
| Net Income to Common | -5.2 | -7.14 | -6.45 | -5.97 | -3.42 | -2.98 | Upgrade
|
| Shares Outstanding (Basic) | 124 | 117 | 104 | 91 | 74 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 124 | 117 | 104 | 91 | 74 | 65 | Upgrade
|
| Shares Change (YoY) | 9.24% | 11.96% | 14.98% | 22.25% | 14.03% | 18.54% | Upgrade
|
| EPS (Basic) | -0.04 | -0.06 | -0.06 | -0.07 | -0.05 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.06 | -0.06 | -0.07 | -0.05 | -0.05 | Upgrade
|
| Free Cash Flow | -1.63 | -3.56 | -4.69 | -4.14 | -2.35 | -2.23 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.05 | -0.03 | -0.03 | Upgrade
|
| Operating Margin | -1790.26% | -10665.08% | -42456.11% | - | -127409.72% | -155907.37% | Upgrade
|
| Profit Margin | -2213.22% | -12053.42% | -43014.32% | - | -127409.72% | -160572.07% | Upgrade
|
| Free Cash Flow Margin | -692.17% | -6010.77% | -31251.15% | - | -87617.95% | -120157.86% | Upgrade
|
| EBITDA | -4.17 | -6.29 | -6.36 | -5.93 | -3.42 | -2.89 | Upgrade
|
| D&A For EBITDA | 0.04 | 0.04 | 0 | 0 | 0 | 0 | Upgrade
|
| EBIT | -4.21 | -6.32 | -6.37 | -5.93 | -3.42 | -2.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.